Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair

M Tiburcy, JE Hudson, P Balfanz, S Schlick, T Meyer… - Circulation, 2017 - Am Heart Assoc
Background: Advancing structural and functional maturation of stem cell–derived cardiomyocytes
remains a key challenge for applications in disease modeling, drug screening, and …

[HTML][HTML] Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae

A Daher, P Balfanz, C Cornelissen, A Müller, I Bergs… - Respiratory …, 2020 - Elsevier
Background Since December 2019 the novel coronavirus disease 2019 (COVID-19) has
been burdening all health systems worldwide. However, pulmonary and extrapulmonary …

[HTML][HTML] The characteristics of 50 hospitalized COVID-19 patients with and without ARDS

…, A Kersten, J Bickenbach, P Balfanz… - Deutsches Ärzteblatt …, 2020 - ncbi.nlm.nih.gov
Background The type of pneumonia (coronavirus disease 2019, COVID-19) that is caused
by the new coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) is …

[HTML][HTML] ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19

…, C Elsner, N Babel, P Balfanz… - Pharmacogenetics …, 2021 - journals.lww.com
Objectives The RNA virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is responsible for coronavirus disease 2019 (COVID-19). Cell entry is mediated by the …

[HTML][HTML] Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients

…, J Bungenberg, A Costa, M Dreher, P Balfanz… - … research and practice, 2021 - Springer
Background The SARS-Coronavirus-2 (SARS-CoV-2) invades the respiratory system,
causing acute and sometimes severe pulmonary symptoms, but turned out to also act …

[HTML][HTML] Clinical course of COVID-19 patients needing supplemental oxygen outside the intensive care unit

A Daher, P Balfanz, M Aetou, B Hartmann… - Scientific Reports, 2021 - nature.com
Patients suffering from CVOID-19 mostly experience a benign course of the disease.
Approximately 14% of SARS-CoV2 infected patients are admitted to a hospital. Cohorts exhibiting …

[HTML][HTML] Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients

J Hannemann, P Balfanz, E Schwedhelm… - Scientific reports, 2021 - nature.com
COVID-19 is a disease with a variable clinical course ranging from mild symptoms to critical
illness, organ failure, and death. Prospective biomarkers may help to predict the severity of …

[HTML][HTML] Six months follow-up of patients with invasive mechanical ventilation due to COVID-19 related ARDS

…, C Cornelissen, NU Hartmann, P Balfanz… - International Journal of …, 2021 - mdpi.com
Although patients who recovered from acute coronavirus disease 2019 (COVID-19) may have
prolonged disabilities, follow-up data of those who have survived COVID-19 related acute …

[HTML][HTML] Epigenetic clocks are not accelerated in COVID-19 patients

…, M Vieri, M Nikolić, Y Han, P Balfanz… - International Journal of …, 2021 - mdpi.com
Age is a major risk factor for severe outcome of the 2019 coronavirus disease (COVID-19). In
this study, we followed the hypothesis that particularly patients with accelerated epigenetic …

[HTML][HTML] Glycaemic variability is associated with all-cause mortality in COVID-19 patients with ARDS, a retrospective subcohort study

B Hartmann, M Verket, P Balfanz, NU Hartmann… - Scientific reports, 2022 - nature.com
There is high mortality among intensive care unit (ICU) patients with acute respiratory distress
syndrome (ARDS) caused by coronavirus disease (COVID-19). Important factors for COVID…